Novo Nordisk (NVO) said Sunday that its weight-loss drug Wegovy was associated with improvements in several measures of liver health among patients with a serious liver disease who had a body mass index below 27.
At Srivax, we believe in delivering fast, accurate, and relevant news to empower, inform, and engage our readers across the globe. We are an independent digital news platform built for the modern world — where information moves fast, and truth matters.
